In general, IV bisphosphonates are very well tolerated ... adverse events in both treatment groups were mild to moderate bone pain, nausea, fatigue, and fever ( Table 2). [14] Less than 5% ...

To determine which parameters, including femur morphology, proximal femur bone mineral density, or patient characteristics, are associated with bisphosphonate-related atypical femur fractures (AFFs) ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Osteoporosis treatments fall into two major categories — those that prevent your bones from breaking down (anti-resorptive) and those that increase bone building (anabolic). Women and men with low or ...

we explored the effect of bone-modifying agents (bisphosphonates such as zoledronic acid and denosumab) on OS and progression-free survival in patients with mCRPC with at least 1 bone metastasis using ...

Usually, when you have bone cancer, it comes from another cancer that has spread to your bones or metastatic bone cancer. But sometimes, the cancer cells start in your bones. In that case ...

6. Bone-Modifying Drugs The addition of bisphosphonate therapy has been considered in early-stage breast cancer, as it may reduce the risk for bone metastases. With metastatic breast cancer, systemic ...

suggesting an impairment in bone remodeling around dental implants. Key Words: alendronate; bisphosphonate; bone remodeling; dental implants; osseointegration; rats Osteoporosis is a prevalent ...

Bone metastases are cancers that have spread (metastasized) from other tissues in the body through the blood or lymphatic systems to the bone marrow. Bone metastases form the main type of bone ...

Xgeva (denosumab) has already been approved to treat fractures in patients with multiple myeloma without bone metases, and in patients with bone metastases from solid tumours. It is also indicated ...

Nevertheless, the specific function of MAFG-DT in the context of bone metastasis in PCa remains inadequately understood. Methods: The expression level of MAFG-DT was analyzed in published datasets and ...